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Abstract
Background: The aim of our study was to review the results of microsurgically performed
testicular sperm extraction (TESE) and to evaluate its possible long term effects on serum
testosterone (T).
Methods: We operated on 48 men (35 +/- 8 years) with non-obstructive azoospermia (NOA). If
no spermatozoa were found following a micro epididymal sperm extraction (Silber et al., 1994) and
testicular biopsy, testicular microdissection was performed or multiple microsurgical testicular
biopsies were taken. The mean follow-up of the serum T was 2.4 +/- 1.1 years.
Results: Sperm was retrieved in 17/48 (35%) of the men. The per couple take home baby rate if
sperm was retrieved was 4/17 (24%). Serum T decreased significantly at follow-up (p < 0.05) and
5/31 (16%) de novo androgen deficiencies developed
Conclusion: In patients with non-obstructive azoospermia in whom no spermatozoa were found
following a micro epididymal sperm aspiration and a simple testicular biopsy, we were able to
retrieve spermatozoa in 35% of the men. The take home baby rate was 24% among couples with
spermatozoa present upon TESE. De novo androgen deficiency occurred in 16% of the male patients
following TESE indicating that, in men with NOA, long term hormonal follow up is recommended
after TESE.
Background
For men with non-obstructive azoospermia (NOA),
retrieval of spermatozoa from the testes for assisted repro-
duction using intracytoplasmic sperm injection (ICSI)
offers an opportunity for fertility despite limited sperm
production [1-4]. The technique of testicular sperm
extraction (TESE) via an open testicular biopsy was
described for obstructive azoospermia by Schoysman et
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et al. [7] and Devroey et al. [1] for NOA.
Failure to extract spermatozoa may occur in up to 57% of
TESE attempts [1-3,8,9]. Some authors have suggested a
single large biopsy, others perform multiple smaller biop-
sies, and still others have reported excising a majority of
the volume of the testis in an effort to sample enough tis-
sue to extract spermatozoa from [10]. Multiple testicular
biopsies can result in the loss of significant amounts of
testicular tissue and can interrupt the testicular blood sup-
ply underneath the tunica albuginea with risks of testicu-
lar devascularization and subsequent atrophy of the testis
[11].
In 1999 Schlegel et al. [12] reported on novel microsurgi-
cal techniques for TESE. They used an operating micro-
scope to identify regions containing spermatozoa in the
testes of men with NOA and performed multiple biopsies
while avoiding the subtunical blood vessels. The tech-
nique is further referred to as microsurgical multiple tes-
ticular biopsies (Micro TESE). Subsequently, Schlegel et
al. [12] achieved better retrieval rates using a microdissec-
tion technique (Microdissection TESE) while the amount
of testicular tissue excised was reduced. The concept was
simple: seminiferous tubules with Sertoli cells only (SCO)
are thinner than tubules containing spermatogenic cells.
The difference between the larger and smaller tubules is
not visible without optical magnification. In Schlegel's
hands this technique of microdissection resulted in an
improvement of sperm retrieval rates from 45 to 63%. In
men where no spermatozoa were found in a non-micro-
surgical single testicular biopsy procedure, the retrieval
rate was 35% [12].
Concerning possible complications, many studies
reported ultrasonographic evidence of residual testicular
damage after TESE (reviewed in Schill et al. [13]). Schlegel
and Su [11] reported complete testicular atrophy in two
out of 64 patients following non-microsurgical TESE. Vas-
cular damage can lead to a decrease of Leydig cell function
causing a decrease of serum testosterone (T) level. Andro-
gen deficiency may have serious long-term health conse-
quences [14].
Manning et al. [15] described a decrease in serum T levels
following non-microsurgical TESE in patients with NOA
for up to one year after the procedure. Schill et al. [13]
reported no decrease in serum T levels in patients with
azoospermia after an average of 18 months following
non-microsurgical TESE. However, the same study indi-
cated that patients with NOA had lower serum T levels
and that T response to human chorionic gonadotrophin
(HCG) stimulation were more frequently impaired com-
pared to men with obstructive azoospermia [16]. There-
fore, they concluded that patients with NOA show an
increased risk of androgen deficiency following non-
microsurgical TESE and recommended long-term follow-
up in this group of patients [16]. To date, there are few
data on the long-term effects of TESE performed by micro-
surgery. One month after microdissection TESE, Hibi et al.
[17] found no decrease in serum testosterone in 4 patients
with NOA. Needle aspiration of testicular spermatozoa
had no adverse effect on serum testosterone after up to
nine months of follow-up [18].
So far, no serious adverse effects have been published fol-
lowing microsurgical TESE, qualifying these procedures as
safe. Theoretically one should expect fewer complications
compared to a classic testicular biopsy since better visual-
isation should lead to better safekeeping of the testicular
end-arteries.
The aim of the study was to evaluate the outcome of micro
TESE and microdissection TESE, and the possible long-
term effects of these procedures on Leydig cell function as
reflected by serum testosterone levels.
Methods
Study design
We retrospectively evaluated the outcome of microsurgi-
cal TESE in patients with NOA treated at the Ghent Uni-
versity Hospital, Belgium during the period January 1999
to June 2001. Only patients with a follow up of more then
1 year were included. Baseline data were available for all
patients. Patients in whom postoperative hormonal data
was missing were invited by mail to have a blood sample
taken for the determination of serum hormones. The
study was performed with the approval of the ethics com-




During the period from January 1999 till June 2001, 48
patients with NOA treated by microsurgical TESE were
identified in our hospital records. All men were examined
pre-operatively according to the recommendations of the
World Health Organization [19]. Azoospermia was
proven in at least 2 ejaculates after centrifugation. Clinical
postoperative evaluation was available in only 8 patients
(39 patients were secondary referrals of whom 32 from
abroad).
Hormonal measurements
Commercial kits for radioimmunoassay were used to
determine the serum concentrations of testosterone
(Medgenics Diagnostics, Fleurus, Belgium); commercial
kits for immuradiometric assays were used for determina-
tions of LH and FSH (Medgenics Diagnostics). Intra- andPage 2 of 6
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below 10 and 15%, respectively.
Hormonal data were available on 45 patients at baseline.
In March 2003 postoperative hormones levels were avail-
able from 31 out of the 45 patients. Patients with de novo
androgen deficiency were asked to perform a second
blood analysis. All blood samples were taken between 8
and 10 h 00 a.m.
In our laboratory, the minimal reference value for testo-
sterone is 280 ng/dl. Biochemical androgen deficiency
was diagnosed if testosterone levels in serum were below
the reference value on 2 occasions.
Surgical procedures
Surgery was performed on the day of the ovum pick-up in
23 patients while in 25 patients the previously retrieved
frozen spermatozoa were used. Under general anaesthesia
a median scrotal incision was performed and both testi-
cles were exposed. Since we do not perform a pre-opera-
tive testicular biopsy, a micro epididymal sperm
extraction was attempted in all patients together with a
small single microsurgical testicular biopsy at the midline
of the testis avoiding blood vessels [12]. If no spermato-
zoa were found, an operating microscope was used to
obtain multiple biopsies (Micro TESE) if apparently nor-
mal seminiferous tubules were seen at the initial testicular
biopsy (n = 31). With the use of an operating microscope,
subtunical blood vessels are avoided as much as possible.
If hairy or no seminiferous tubules were found [12] a
microdissection TESE was performed (n = 17). The testes
were incised and with the use of optical magnification, the
larger tubules were excised, because of the greater chance
of finding spermatogenic cells in these larger tubules.
Testicular histopathology was evaluated according to the
method described by Johnsen [20] and was available for
46 out of 48 patients.
The female Partner
The mean age of the female partners was 31 years with a
standard deviation (SD) of 5 years. They were all treated
with a short gonadotrophin-releasing hormone analogue
protocol, followed by HCG. Oocytes were retrieved at our
centre or in a transport setting [21], by transvaginal ultra-
sound-guided puncture of the ovarian follicles. ICSI was
performed as previously described by our group [22] and
2 to 3 embryos were transferred.
Biochemical pregnancy was assessed by measuring serum
HCG at least 15 days following embryo transfer on two
successive occasions, and clinical pregnancy was ascer-
tained by ultrasound at 6 weeks.
Statistical analysis
Data are presented as mean +/- SD. Statistical analysis is
performed using a Student t-test (paired when applica-
ble), and Chi2-test (MedCalc, MedCalc Software, Mari-
akerke, Belgium).
Results
A summary of the medical history, physical examination
and hormone levels obtained at the initial evaluation of
male partner is presented in Table 1. The mean follow-up
period was 2.4 years (+/- 1.1 years).
Complications of surgical procedures
Mild pain lasting 3–14 days was reported by all patients,
while 2 patients complained of more severe pain lasting 1
month or more. Oral analgesics were needed during on
average 6 days (rage 0–90 days). Surgery for haematoma
was never needed. In 1 patient, unilateral cryptorchidism
reoccurred after surgery and surgical revision of the
wound was necessary in one patient with a spinal cord
injury.
Results of hormone determinations
Four out of 45 patients (8%) had serum testosterone lev-
els below the reference range of our laboratory at the pre-
operative evaluation (280 ng/dl).
Hormonal follow-up was available on 31 patients. A com-
parison between levels of serum hormones before TESE
and at follow-up is presented in Table 2. Serum testoster-
one levels were on average 10 per cent lower at follow-up
compared to pre-operative levels (p < 0.05). Five out of 31
patients (16%) were found to have a de novo androgen
deficiency at follow-up. As these patients were foreigners
no follow-up clinical data are available and patients were
advised to seek medical help in their country. Among the
8 patients of whom a clinical evaluation was available
during postoperative follow-up, no symptoms or signs of
androgen deficiency were noted. They all also had normal
testosterone levels both preoperatively and at the follow-
up visit (433 +/- 99 ng/dl) (paired t-test: p > 0.05). No sig-
nificant correlations were found between serum T and
either age of the male partner or testicular volume (data
not shown).
Table 2 also shows that serum levels of FSH and LH were
slightly but not significantly increased at follow-up (p =
0.07, for both hormones).
Sperm retrieval and conception rates
Spermatozoa were retrieved in 17 out of 48 patients
(35.4%). 28 cycles of ICSI were performed in 17 couples
with native spermatozoa present, and in 5 couples with
donor spermatozoa of whom 2 cycles without embryo
transfers. In September 2002, 53 embryo transfers werePage 3 of 6
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1 vanishing twin, 5 pregnancies and 4 babies (24%)
among couples with spermatozoa present upon TESE.
Fresh spermatozoa (n = 8 out of 25 men) resulted in 2
babies and frozen (n = 9 out of 23 men) in 2 babies.
Discussion
To the best of our knowledge the first study this is report-
ing the long-term effects of microsurgical TESE in patients
with NOA. Manning et al. [15] found that testosterone
levels decreased initially after non-microsurgical TESE in
most patients with partial recovery after 1 year. In our
study only patients with a follow up of longer than 1 year
were included. Other studied reported no decrease in
serum testosterone [13,17,18]. Comparing our results to
these studies is difficult due to the diverse techniques used
to retrieve spermatozoa and different durations of post-
operative follow-up.
Our results indicate that microsurgical TESE is associated
with a significant long-term decrease of serum T levels. A
relatively high incidence of T deficiency was recorded pre-
operatively (8%) as well as after an average of 2.4 years of
follow-up. It is generally agreed that testosterone
decreases with age in the male [14]. However, it is unlikely
that age per se is a major contributing factor to T deficiency
in our patients since they were relatively young with a
mean age of 34 years. Furthermore, T levels did not corre-
late significantly with age. On the other hand, patients
with NOA are more prone to develop premature "andro-
pause" due to the presence of testicular pathology, which
effects are difficult to distinguish from those of TESE on
serum T. As shown in Table 1, our patients had a total tes-
ticular volume which is on average at lower end of nor-
mality (30 ml) before surgery. So, Microsurgical TESE can
be a reason of T deficiency but other factors, which can
gradually compromise the Leydig cell function (e.g. cryp-
torchidism, testicular torsion, chemotherapy) should
always be taken in consideration when the testosterone
level declines. Further studies are needed to find the major
contributing factor of long-term androgen deficiency after
microsurgical TESE.
If one accepts that the observed decline in serum T is
caused by TESE, several mechanisms may be responsible
for the observed decline of serum T. These include loss of
testicular tissue removed during surgery, surgical trauma
and inflammation [11]. Also vascular injury to the testis
can result from testicular surgery. Testicular blood supply
penetrates the tunica albuginea and runs under the tunica
before penetrating between the septa separating the sem-
iniferous tubules. Therefore, these arteries are end-arter-
ies[23]. Injury to these small arteries may cause
devascularisation of a region of the testis. Schlegel and Su
[11] reported that 82% of the patients who underwent a
TESE procedure, had intratesticular abnormalities on
ultrasound as long as 3 months afterwards. Most of the
lesions seemed to disappear 6 months after TESE leaving
only linear scars visible on ultrasound.
Patients need to be informed on the long-term conse-
quences of TESE, including possible androgen deficiency
and its therapy[13]. Before starting substitution therapy it
seems advisable to wait for about 1 year after the surgery
since some degree of spontaneous recovery may occur
[15].
As our study is not a comparative evaluation of techniques
(micro TESE vs. microdissection TESE), no conclusions
can be drawn regarding which technique of microsurgery
is to be preferred in the future. Anyhow, no significant dif-
ferences in outcome and postoperative hormones were
found.
Due to the adverse effect of TESE on serum T reported in
this study, it is recommended that, whenever possible, an
etiological treatment of the azoospermia should be
attempted before resorting to TESE. For example, the treat-
ment of varicocele and hypogonadal hypogonadism may
result in the appearance of spermatozoa in the ejaculate
and, in some cases, spontaneous pregnancy [16,24].
The take home baby rate of 24% among couples with
spermatozoa present upon TESE is similar to the success
rate of IVF or ICSI (25%) for other indications in our pro-
gram [25]. This illustrates that the finding of sperm is the
crucial step in patients with NOA, but once this step is suc-
cessfully taken, the chances of getting normal fertilization,
embryo development and pregnancy rates are the same as
in any other couple.
Conclusion
Among patients with NOA, in whom no spermatozoa are
found following a micro-epididymal sperm aspiration
and a simple testicular biopsy, we were able to retrieve
spermatozoa in 35% by means of multiple microsurgical
testis biopsies or testicular microdissection. The per cou-
ple take home baby rate was 24%. Long-term androgen
deficiency is a potential risk of TESE and patients with
NOA need to be informed about this possible complica-
tion.
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